Local News: Ashburn, VA 

 | 

Sign Up

 | 

Sign In

Johnson and Johnson

Johnson and Johnson News Editors

News Widget

Display the Johnson and Johnson news headlines on your website.

Get the Topix Headlines Widget

Share & bookmark

RSS icon mobile icon

Johnson and Johnson News

News on Johnson and Johnson (Ticker: JNJ) continually updated from thousands of sources around the net.

4 hrs ago | The Motley Fool

How Dividends Change the Game for Johnson & Johnson Stock

The single, easiest way to keep track of all the stocks that matter... Your own personalized stock watchlist! It's a 100% FREE Motley Fool service... The wealth-building power of compound interest will never cease to amaze me.

Comment?

Related Topix: Johnson & Johnson, Biotech, Medicine, Healthcare Industry, Financial Markets, Food, J and J Snack Foods

8 hrs ago | In-PharmaTechnologist.com

Janssen's Manufacturing Problems May Lead to Criminal Charges in Korea

Though Janssen Korea says it is confident it will resolve its manufacturing issues, product recall and suspensions could be followed by lawsuits and imprisonment.

Comment?

Related Topix: Prison, Johnson & Johnson, Biotech, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Tylenol, Tempra, Acetaminophen (generic)

17 hrs ago | PR-inside.com

Peterborough Staff Help Company Achieve 'Best In The World' Ranking

The study saw more than 400 patient groups from 39 different countries assessing 30 'medtech' companies on their ability to meet patient expectations.

Comment?

Related Topix: Johnson & Johnson, Biotech, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry

Sun May 19, 2013

The Motley Fool

Will Obamacare Crush Medtronic's Earnings?

The key to making smart investment decisions on stocks reporting earnings is to anticipate how they'll do before they announce results, leaving you fully prepared to respond quickly to whatever inevitable surprises arise.

Comment?

Related Topix: Financial Markets, Johnson & Johnson, Biotech, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, DePuy Orthopaedics, Medical Equipment, Hospital Administration, St Peters Health Care Services

Sat May 18, 2013

Patch.com

Avon CEO to Address Stonehill College Graduates

Sheri S. McCoy, the chief executive officer and a director of Avon Products, will deliver the keynote address at Stonehill College's 62nd Commencement on Sunday, May 19.

Comment?

Related Topix: Avon Products, Household Products, Stonehill College, Johnson & Johnson, Biotech, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Saint Edward's University

Fri May 17, 2013

BayStreet.ca

Investment Ideas in the Expanding Wound Care Market

The wound care market may not be the most exciting biotech niche on the surface, but the multi-billion dollar industry's need for innovation has created an opportunity for smaller companies operating in the space.

Comment?

Related Topix: Medicine, Diabetes, Health, Biotech, Smith and Nephew, Medical Equipment, Healthcare Industry, American CryoStem

BioSpace

Johnson & Johnson Outlines Poppy Supply Plans

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today! Johnson and Johnson could be sourcing commercial quantities of poppies outside Tasmania in 2015.

Comment?

Related Topix: Johnson & Johnson, Biotech, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Startups, Acclarent, DePuy Orthopaedics, Medical Equipment, Hospital Administration, St Peters Health Care Services

The Washington Post

Johnson & Johnson Ending Sales of Metal-on-Metal Hip Implants

Johnson & Johnson, the world's biggest maker of health-care products, said it will stop selling metal-on-metal and ceramic-on-metal hip replacements as demand wanes for the devices and U.S. regulators seek new rules.

Comment?

Related Topix: Johnson & Johnson, Biotech, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, DePuy Orthopaedics, Medical Equipment, VisionCare Ophthalmic Technologies, Startups, OrthoClinical Diagnostics

Econsultancy

Five lessons in corporate brand building from the big boys

Research by media monitoring company Precise, published in March 2013 says that consumers are more likely to view FMCG companies favourably if they develop a recognisable corporate brand.

Comment?

Related Topix: Johnson & Johnson, Biotech, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Advanced Transit Dynamics, Johnson Controls, LOC-AID Technologies

Thu May 16, 2013

Nonwovens Industry

EDANA members elect new board

EDANA, the Association Serving the Nonwovens and Related Industries, has announced its new board of governors for 2013-2015, the most international board ever the group says with representatives from across Europe, the Middle East, United States and Asia.

Comment?

Related Topix: Johnson & Johnson, Biotech, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Gerd, Electronic

Jerusalem Post

Retirement investors: Dividend or valued stocks?

With interest rates near zero, investors have been desperately seeking yield. As a result, one of the hottest trades for investors over the last three to four years has been buying large companies that pay high dividends.

Comment?

Related Topix: Financial Markets, Personal Finance, Retirement, Johnson & Johnson, Biotech, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry

Seeking Alpha

Johnson & Johnson, Medtronic Frontrunners In Race To Develop Artificial Pancreas

A small implantable device, an artificial pancreas would continuously monitor blood-sugar levels and release insulin as needed in patients with Type 1 diabetics.

Comment?

Related Topix: Medtronic, Medicine, Medical Equipment, Healthcare Industry, Insulin (generic), Humulin, Novolin, Biotech, 9, Healthcare Law, Law, Diabetes, Health

Seeking Alpha

Johnson & Johnson: At The Crossroads - Part III

In Part I of "Johnson & Johnson: At The Crossroads", consideration was given to whether a dividend growth rate of 8.2% was sustainable if net income growth rate remained around the projected 6%. It was determined that this gap between dividend and net income growth rates was likely sustainable for at least the next 15 years.

Comment?

Related Topix: Johnson & Johnson, Biotech, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, VisionCare Ophthalmic Technologies, Startups, Scios, OrthoClinical Diagnostics, Medical Equipment

Seeking Alpha

JPMorgan - Why I'm All In With Jamie Dimon

After listening to the media trash JP Morgan's Jamie Dimon for the past year, and following the recent uproar caused by proxy firm recommendations that shareholders vote to separate the company's Chairman and CEO functions, I simply cannot sit by any longer without speaking up in Dimon's defense.

Comment?

Related Topix: Banking, JP Morgan Chase , Biotech, Medicine, Healthcare Industry

Wed May 15, 2013

Grist Magazine

This app helps you avoid supporting Monsanto and other terrible companies

When shopping in any store that carries national brands, it's virtually impossible to remember which ones you're not supposed to buy for which reasons.

Comment?

Related Topix: Johnson & Johnson, Biotech, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry

The Washington Post

J&J Wins Expanded Approval of Simponi to Treat Bowel Disease

Johnson & Johnson won U.S. approval to use its rheumatoid arthritis drug Simponi to treat patients suffering from a moderate to severe inflammatory bowel disease.

Comment?

Related Topix: Johnson & Johnson, Biotech, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Advanced Transit Dynamics, VisionCare Ophthalmic Technologies, Startups, Johnson Controls

TheStreet.com

Stryker's Stock Looks Pricey

Assessing whether a stock is a "value play" or a "value trap" has become a popular hobby for financial writers.

Comment?

Related Topix: Johnson & Johnson, Biotech, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Startups, Acclarent, DePuy Orthopaedics, Medical Equipment, Hospital Administration, St Peters Health Care Services

Tue May 14, 2013

BioSpace

What Did She Do? Congress Probes Departure of FDA Official

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today! In one of the more curious departures of a high-ranking FDA official, Leona Brenner-Gati unexpectedly resigned from the agency earlier this month and did so immediately for unexplained personal reasons.

Comment?

Related Topix: Johnson & Johnson, Biotech, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry

MarketNewsVideo

XLV, UWM: Big ETF Outflows

Turning today to week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, the largest outflow was seen in the Health Care Select Sector SPDR Fund , which shed 22.3 million shares, or a 13.4% decrease week over week.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Pfizer, Business News, Video

BioSpace

Johnson & Johnson Unit Gets Priority Revenue for Simeprevir NDA

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today! Johnson & Johnson unit Janssen Research and Development LLC said the U.S. Food and Drug Administration has granted priority review to its new drug application for simeprevir, its investigational treatment of genotype 1 chronic hepatitis C in adult patients ... (more)

Comment?

Related Topix: Johnson & Johnson, Biotech, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Advanced Transit Dynamics, VisionCare Ophthalmic Technologies, Startups, LOC-AID Technologies

Ashburn Jobs